Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Eyebrow Hypotrichosis: A Phase 4 Investigator Initiated Study

Trial Profile

Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Eyebrow Hypotrichosis: A Phase 4 Investigator Initiated Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs Bimatoprost (Primary)
  • Indications Hypotrichosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top